<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04090372</url>
  </required_header>
  <id_info>
    <org_study_id>14 7426 15</org_study_id>
    <nct_id>NCT04090372</nct_id>
  </id_info>
  <brief_title>Digital Preop-planning of Total Hip Arthroplasties</brief_title>
  <acronym>PLANORTHO</acronym>
  <official_title>Digital Preop-planning of Total Hip Arthroplasties in Orthopedic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Residual leg length discrepancy is a common issue after total hip arthroplasty(THA). Digital
      preoperative planning may improve the accuracy of the surgical procedure and may help the
      surgeon to precisely predict implants sizes
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Total hip arthroplasties (THAs) are used to restore locomotion. More than 150,000 THAs are
      performed each year in France. Better outcomes require a restoration of limb lengths and
      anatomy. Post-operative discrepancy is the main cause of complaints and financial
      compensation in the US after THA. As such, the investigators aim to use preoperative digital
      planning using TraumaCad to optimize the restoration of the center of rotation of the hips.
      Preoperative planning are usually performed using anteroposterior standard radiographs, which
      are scaled to an inaccurate scale. The TraumaCad system (BrainlabÂ®) allows the adjustment of
      the scales to each patient and the virtual positioning of the implants in order to simulate
      the intervention for the restitution of the geometrical parameters of the hip.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 9, 2019</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative residual discrepancy</measure>
    <time_frame>day 3</time_frame>
    <description>The primary endpoint is the postoperative residual discrepancy measured on the radiographs on postop day 3 in millimeter compared using standard planning methods compared to TraumaCad.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>comparisons of the reproducibility of the femoral implants sizes</measure>
    <time_frame>day 3</time_frame>
    <description>Secondary endpoints is comparisons of the reproducibility of the femoral implants sizes predicted by the software</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>comparison of pelvis parameters</measure>
    <time_frame>day 3</time_frame>
    <description>Secondary endpoints is the comparison of pelvis parameters in the 2 groups (offset, positioning of the implants) postoperatively. The angle of femur axis and the center of rotation of hip will be measure on the radiography of day 3</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Orthopedic Disorder</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Control group will be assessed by standard preop planning using implants templates.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TraumaCad Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TraumaCad Group will be assessed by preop planning using Traumacad</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>evaluation of pre-op planning using Traumacad</intervention_name>
    <description>The study will be compare pre-op planning with standard condition or with TraumaCad</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>TraumaCad Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  being older than18 years,

          -  osteoarthritis as the indication for THA

        Exclusion Criteria:

          -  THAs after femoral neck fractures,

          -  revision surgery,

          -  major architectural anomaly (Bone tumor, prior fracture of the pelvis, hip dysplasia),

          -  patients under legal protection,

          -  pregnancy or breast-feeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nicolas Reina, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Toulouse, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicolas Reina, MD</last_name>
    <phone>05.61.77.55.78</phone>
    <phone_ext>33</phone_ext>
    <email>Reina.n@chu-toulouse.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Reina, MD</last_name>
      <phone>05.61.77.55.78</phone>
      <phone_ext>33</phone_ext>
      <email>Reina.n@chu-toulouse.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 10, 2019</study_first_submitted>
  <study_first_submitted_qc>September 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2019</study_first_posted>
  <last_update_submitted>September 12, 2019</last_update_submitted>
  <last_update_submitted_qc>September 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Osteoarthritis</keyword>
  <keyword>Hip</keyword>
  <keyword>Total hip arthroplasty</keyword>
  <keyword>leg discrepancy</keyword>
  <keyword>preoperative planning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Musculoskeletal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

